Literature DB >> 34155581

Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods.

Filipa C Santos1, Paulo J Costa2, M Helena Garcia1, Tânia S Morais3.   

Abstract

The interaction between human serum transferrin (hTf) and three promising organometallic Ru (II)- (η5-C5H5) derived complexes, that have already shown strong in vitro cytotoxicity towards human cancer cell lines, has been investigated using fluorescence spectroscopic techniques. The results suggested that the formation of Ru-hTf systems involves a dynamic collision. The binding process occurs spontaneously (ΔG < 0), mainly driven by hydrophobic interactions. Additional docking studies show that all complexes bind preferably to a specific hydrophobic pocket in the C2-subdomain as already observed for other metal-cyclopentadienyl (MCp) complexes and are in agreement with the experimental results. With these studies we hope to contribute to the understanding of the mechanism of action of these promising cytotoxic agents, thus providing clues for a more rational design.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Docking simulations; Fluorescence spectroscopy; Human serum transferrin; Metallodrugs; Metal–protein interaction; Ruthenium (II)

Mesh:

Substances:

Year:  2021        PMID: 34155581     DOI: 10.1007/s10534-021-00325-w

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  22 in total

1.  Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.

Authors:  Angela Casini; Christian Hartinger; Chiara Gabbiani; Enrico Mini; Paul J Dyson; Bernard K Keppler; Luigi Messori
Journal:  J Inorg Biochem       Date:  2007-11-28       Impact factor: 4.155

2.  Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes.

Authors:  Leonor Côrte-Real; Filipa Mendes; Joana Coimbra; Tânia S Morais; Ana Isabel Tomaz; Andreia Valente; M Helena Garcia; Isabel Santos; Manuel Bicho; Fernanda Marques
Journal:  J Biol Inorg Chem       Date:  2014-02-23       Impact factor: 3.358

3.  Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools.

Authors:  Lurdes Gano; Teresa Pinheiro; António P Matos; Francisco Tortosa; Tiago F Jorge; Maria S Gonçalves; Marta Martins; Tânia S Morais; Andreia Valente; Ana I Tomaz; Maria H Garcia; Fernanda Marques
Journal:  Anticancer Agents Med Chem       Date:  2019       Impact factor: 2.505

4.  Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin.

Authors:  Floyd Beckford; Jeffrey Thessing; Jason Woods; Jacob Didion; Nikolay Gerasimchuk; Antonio Gonzalez-Sarrias; Navindra P Seeram
Journal:  Metallomics       Date:  2011-02-23       Impact factor: 4.526

5.  Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.

Authors:  Michael Groessl; Erwin Reisner; Christian G Hartinger; Rene Eichinger; Olga Semenova; Andrei R Timerbaev; Michael A Jakupec; Vladimir B Arion; Bernhard K Keppler
Journal:  J Med Chem       Date:  2007-04-03       Impact factor: 7.446

6.  Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugs.

Authors:  Leonor Côrte-Real; António P Matos; Irina Alho; Tânia S Morais; Ana Isabel Tomaz; Maria Helena Garcia; Isabel Santos; Manuel P Bicho; Fernanda Marques
Journal:  Microsc Microanal       Date:  2013-06-24       Impact factor: 4.127

7.  Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form.

Authors:  Olga Mazuryk; Katarzyna Kurpiewska; Krzysztof Lewiński; Grażyna Stochel; Małgorzata Brindell
Journal:  J Inorg Biochem       Date:  2012-07-29       Impact factor: 4.155

8.  Transport of therapeutic vanadium and ruthenium complexes by blood plasma components.

Authors:  J Costa Pessoa; I Tomaz
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

9.  A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides.

Authors:  Jorge R Güette-Fernández; Enrique Meléndez; Wilson Maldonado-Rojas; Carlos Ortega-Zúñiga; Jesus Olivero-Verbel; Elsie I Parés-Matos
Journal:  J Mol Graph Model       Date:  2017-05-30       Impact factor: 2.518

10.  Interaction of colchicine with human serum albumin investigated by spectroscopic methods.

Authors:  Yan-Jun Hu; Yi Liu; Ru-Ming Zhao; Song-Sheng Qu
Journal:  Int J Biol Macromol       Date:  2005-10-18       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.